Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Isis 301012
2. Isis-301012
3. Isis301012
4. Kynamro
5. Mipomersen
1. Mipomersen Sodium Salt
2. Chembl502097
3. Dtxsid20212108
| Molecular Weight | 7595 g/mol |
|---|---|
| Molecular Formula | C230H305N67Na19O122P19S19 |
| Hydrogen Bond Donor Count | 26 |
| Hydrogen Bond Acceptor Count | 157 |
| Rotatable Bond Count | 156 |
| Exact Mass | 7591.7553328 g/mol |
| Monoisotopic Mass | 7589.7486232 g/mol |
| Topological Polar Surface Area | 3080 Ų |
| Heavy Atom Count | 476 |
| Formal Charge | 0 |
| Complexity | 20500 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 70 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 20 |
| 1 of 2 | |
|---|---|
| Drug Name | Kynamro |
| PubMed Health | Mipomersen (Injection) |
| Drug Classes | Antihyperlipidemic |
| Drug Label | KYNAMRO (mipomersen sodium) Injection is a sterile, preservative-free, clear, colorless to slightly yellow, aqueous solution for subcutaneous injection. KYNAMRO is supplied in single-use, 2 mL, clear glass vials or single-use, 1 mL, clear glass pre... |
| Active Ingredient | Mipomersen sodium |
| Dosage Form | Solution |
| Route | Subcutaneous |
| Strength | 200mg/ml (200mg/ml) |
| Market Status | Prescription |
| Company | Genzyme |
| 2 of 2 | |
|---|---|
| Drug Name | Kynamro |
| PubMed Health | Mipomersen (Injection) |
| Drug Classes | Antihyperlipidemic |
| Drug Label | KYNAMRO (mipomersen sodium) Injection is a sterile, preservative-free, clear, colorless to slightly yellow, aqueous solution for subcutaneous injection. KYNAMRO is supplied in single-use, 2 mL, clear glass vials or single-use, 1 mL, clear glass pre... |
| Active Ingredient | Mipomersen sodium |
| Dosage Form | Solution |
| Route | Subcutaneous |
| Strength | 200mg/ml (200mg/ml) |
| Market Status | Prescription |
| Company | Genzyme |
treatment of cholesterol and hypercholesterolaemia,
Treatment of heterozygous and homozygous familial hypercholesterolaemia
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
Oligodeoxyribonucleotides, Antisense
Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize. (See all compounds classified as Oligodeoxyribonucleotides, Antisense.)
C10AX11
Related Excipient Companies
Digital Content 
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Mipomersen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mipomersen, including repackagers and relabelers. The FDA regulates Mipomersen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mipomersen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mipomersen supplier is an individual or a company that provides Mipomersen active pharmaceutical ingredient (API) or Mipomersen finished formulations upon request. The Mipomersen suppliers may include Mipomersen API manufacturers, exporters, distributors and traders.
Mipomersen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mipomersen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mipomersen GMP manufacturer or Mipomersen GMP API supplier for your needs.
A Mipomersen CoA (Certificate of Analysis) is a formal document that attests to Mipomersen's compliance with Mipomersen specifications and serves as a tool for batch-level quality control.
Mipomersen CoA mostly includes findings from lab analyses of a specific batch. For each Mipomersen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mipomersen may be tested according to a variety of international standards, such as European Pharmacopoeia (Mipomersen EP), Mipomersen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mipomersen USP).
LOOKING FOR A SUPPLIER?
